ArticleOncotarget2017

Histone lysine methyltransferase G9a is a novel epigenetic target for the treatment of hepatocellular carcinoma.

Masayuki Yokoyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.